Neuropace Inc (NPCE) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $15.02
• Market Cap: $490.29M
• EPS: $-0.75
• 52-Week High: $18.98
• 52-Week Low: $7.56

Market Sentiment

Neuropace Inc currently has a Bullish sentiment score of 0.19.

About Neuropace Inc

NeuroPace, Inc., based in Mountain View, California, is a leader in neuromodulation innovation dedicated to addressing neurological disorders, particularly epilepsy. The company's flagship RNS System delivers responsive brain stimulation to significantly reduce seizures in patients resistant to traditional therapies. As NeuroPace advances its commitment to improving patient outcomes and expands its market reach, it presents a compelling opportunity for institutional investors interested in th...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Neuropace Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does NPCE pay dividends?

Neuropace Inc (NPCE) does not currently pay a regular dividend.

What is NPCE's market cap?

Neuropace Inc (NPCE) has a market capitalization of $490.29M with a current stock price of $15.02.